DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ACADIA Pharmaceuticals Inc. (ACAD)
« Back to company indexACAD Chatter Timeline
Stock Ticker for ACAD
Most Active Tweeters for ACAD
| User | Tweets |
|---|---|
| @SwingTradeBot | 3 |
| @Gambiste1 | 3 |
| @AmericanBanking | 3 |
| @Marko_Sivec | 2 |
| @SeasonalEdge | 2 |
Recent Tweets for ACAD
 |
@SwingTradeBot Rose Above 50 DMA today: $ACAD $POLA ... https://t.co/qwiJH6vr1O June 17th 2019, 12:06pm |
|
@SwingTradeBot $ACAD technical alerts: Fell Below 20 DMA, Fell Below 50 DMA, MACD Bearish Centerline Cross, MACD... https://t.co/bE2LrE6Q53 June 17th 2019, 8:06am |
 |
@1MinuteStock Wondering about risks of $ACAD? The 21-day volatility is 13.29% https://t.co/HMcblgz7pY June 17th 2019, 7:06am |
 |
@Marko_Sivec $ACAD Gold medical of the future...#MEDICAL #NUPLAZID #PIMAVANSERIN June 16th 2019, 4:06pm |
 |
@dailypoliticaln Zacks: Brokerages Anticipate ACADIA Pharmaceuticals Inc. $ACAD Will Announce Quarterly Sales of $73.07 Million https://t.co/IRdh47Ls7B June 16th 2019, 2:06pm |
 |
@TickerReport -$0.46 EPS Expected for ACADIA Pharmaceuticals Inc. $ACAD This Quarter https://t.co/zCRWnsWiX8 June 16th 2019, 2:06pm |
 |
@Gambiste1 RT @DataTrials: $ACAD Phase 2 Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression… Estimated Primary Comp… June 16th 2019, 12:06pm |
 |
@DataTrials $ACAD Phase 2 Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression… Estimated Prim… https://t.co/C2YvH9xH0p June 16th 2019, 11:06am |
 |
@TranscriptDaily ACADIA Pharmaceuticals Inc. $ACAD Receives $29.00 Consensus PT from Analysts https://t.co/VkzPIjPWXb June 16th 2019, 10:06am |
 |
@dispatchtribune ACADIA Pharmaceuticals $ACAD Shares Down 5.3% https://t.co/m6RKzdNpMd June 14th 2019, 11:06pm |
 |
@WeekHerald Analysts Expect ACADIA Pharmaceuticals Inc. $ACAD to Announce -$0.46 EPS https://t.co/DHzICIdCzJ June 14th 2019, 12:06pm |
 |
@bbnsnews ACADIA Pharmaceuticals Inc. $ACAD Expected to Announce Quarterly Sales of $73.07 Million https://t.co/UKO04j6fSt June 14th 2019, 11:06am |
 |
@ArthurHill The noose is tightening as Acadia Pharma consolidates within an uptrend. $ACAD https://t.co/fTDWcIZ5Aq June 13th 2019, 9:06am |
 |
@tq_equities $ACAD finds support at 50-day moving average: https://t.co/ypBHvq1at6 Sentiment: Neutral #ACAD #Acadia June 12th 2019, 4:06pm |
 |
@FlynancialA $ACAD so much potential here https://t.co/JwmOLRFpVm June 12th 2019, 4:06pm |
 |
@SeasonalEdge Daily trading range of $ACAD https://t.co/TxSidopxfY https://t.co/L8NjsLz2Gc June 12th 2019, 10:06am |
|
@Gambiste1 RT @ForTheRecord01: $acad will report the 2nd largest QoQ growth in Nuplazid's history in early August. 2Q sales are expected to come in ar… June 12th 2019, 3:06am |
|
@ForTheRecord01 $acad will report the 2nd largest QoQ growth in Nuplazid's history in early August. 2Q sales are expected to come i… https://t.co/nM4Svh1UpT June 12th 2019, 2:06am |
 |
@AmericanBanking ACADIA Pharmaceuticals Inc. $ACAD Given Average Recommendation of “Buy” by Brokerages https://t.co/VaFUJYcUta #stocks June 11th 2019, 12:06pm |
 |
@ProVesting $ACAD: ACADIA Pharmaceuticals Inc.’s (NASDAQ:ACAD) Profit Outlook: https://t.co/YDgViaaHVr June 11th 2019, 7:06am |
|
@SeasonalEdge Today's insight on $ACAD https://t.co/AsUAAjAeF2 https://t.co/5CjrclDLUS June 11th 2019, 4:06am |
|
@AmericanBanking ACADIA Pharmaceuticals Inc. $ACAD Expected to Post Quarterly Sales of $73.07 Million https://t.co/4P1tyogaxF #stocks June 11th 2019, 1:06am |
 |
@TheMarketsDaily Zacks: Analysts Expect ACADIA Pharmaceuticals Inc. $ACAD Will Post Quarterly Sales of $73.07 Million https://t.co/PEp36LDSyw June 11th 2019, 1:06am |
|
@Marko_Sivec $ACAD Looks very bad,potencial risky...#MEDICAL June 10th 2019, 6:06pm |
 |
@MC_OptionTrades $ACAD $ACAD 14-Jun-19 Straddle Implies a ±5.4% move. Jun 11 Goldman Sachs 40th Annual Global Healthcare Conference https://t.co/xcWwFDROcm June 10th 2019, 8:06am |
 |
@ResearchPool $ACAD #ACADIA Pharmaceuticals Inc. ACAD - Embedded Expectations Analysis - 2019 06 10: ACADIA Pharmaceuticals Inc.… https://t.co/wFtgIjFuEb June 10th 2019, 4:06am |
|
@AmericanBanking -$0.46 Earnings Per Share Expected for ACADIA Pharmaceuticals Inc. $ACAD This Quarter https://t.co/tx1BCMBZPI #stocks June 9th 2019, 8:06pm |
|
@bio_stock @BigChodu I remember a few years ago when $acad backed out of a medical conference and people thought it was a buyo… https://t.co/6GNdBKAh5K June 9th 2019, 12:06pm |
|
@Gambiste1 RT @KrstevskiBranko: Nuplazid sales grow by 5.7% quarter over quarter. $ACAD https://t.co/dBKw189Auz June 9th 2019, 8:06am |
|
@SwingTradeBot Recent $ACAD technical alerts: 180 Bullish Setup plus 14 more alerts... https://t.co/bE2LrE6Q53 June 8th 2019, 9:06am |
 |
@InsiderAlertsIA $ACAD: New Insider Filing on 10%+ Owner BAKER BROS. ADVISORS LP: https://t.co/DtmAJSFaAO June 7th 2019, 6:06pm |
 |
@Biotech2050 @RettDad Status of clinical trial by $ACAD in Rett Syndrome https://t.co/N9IM6FHxwu June 7th 2019, 1:06am |
 |
@Allstocknews $ACAD ACADIA Pharmaceuticals to Present at the Goldman Sachs 40th Annual Global Healthcare Conference From our Stock News Alerts App June 4th 2019, 9:06am |
|
@TheMarketsDaily ACADIA Pharmaceuticals $ACAD Price Target Raised to $43.00 at Raymond James https://t.co/23PgvmnI9b June 4th 2019, 2:06am |
 |
@SleekMoneycom ACADIA Pharmaceuticals $ACAD Price Target Raised to $43.00 at Raymond James https://t.co/W3TBvqgSk8 #investing June 4th 2019, 1:06am |
 |
@stocknewstimes ACADIA Pharmaceuticals $ACAD Price Target Raised to $43.00 at Raymond James https://t.co/FrGEIzJJ7k June 4th 2019, 1:06am |
 |
@revengebets $acad another one how have they not been bought by big pharma $iwm Baker brother has a huge position just surprised June 3rd 2019, 12:06pm |
 |
@ConsumerFeed ACADIA Pharmaceuticals $ACAD PT Raised to $43.00 at Raymond James https://t.co/rEjF6RzBnj June 3rd 2019, 2:06am |
|
@ForTheRecord01 $acad Studies show that Nuplazid works as well or better than the leading antipsychotics on the market:… https://t.co/7hqx1Ubbud June 2nd 2019, 3:06pm |
|
@ForTheRecord01 $acad From December 21, 2018 to April 5, 2019, ACAD rose by over 100%. When did the options market predict this mon… https://t.co/7qm9PEx8fW June 2nd 2019, 3:06pm |
|
@dispatchtribune ACADIA Pharmaceuticals $ACAD Price Target Increased to $43.00 by Analysts at Raymond James https://t.co/EoJukDTygb June 2nd 2019, 2:06am |
|
@AmericanBanking ACADIA Pharmaceuticals $ACAD Rating Reiterated by Raymond James https://t.co/f3f5jgMNxa #stocks May 31st 2019, 5:05pm |
 |
@ChartMill An Altman-Z score of 20.99 indicates that $ACAD is not in any danger for bankruptcy at the moment.… https://t.co/inKf1yuMjk May 30th 2019, 10:05am |
|
@SwingTradeBot $ACAD technical alerts: Expansion Pivot Sell Setup, MACD Bearish Signal Line Cross, MACD Bearish ... https://t.co/bE2LrE6Q53 May 30th 2019, 8:05am |
|
@dispatchtribune ACADIA Pharmaceuticals Target of Unusually High Options Trading $ACAD https://t.co/4XQj2JdGGV May 30th 2019, 7:05am |
|
@AmericanBanking ACADIA Pharmaceuticals Target of Unusually High Options Trading $ACAD https://t.co/5PjARHhfH1 #stocks May 30th 2019, 6:05am |
|
@1MinuteStock Do you know that #Book Value for $ACAD is $2.9 https://t.co/bbT80YnLo4 May 30th 2019, 4:05am |
 |
@SolarMelt $ACAD Without that Put Spread we're looking at a Put Call Ratio of only ~3.66. Still, somebody is awfully bearish a… https://t.co/n3iRTg67k2 May 29th 2019, 7:05pm |
|
@SolarMelt $ACAD You-all seen the Put/Call ratio today? It's a whopping 119.632 (20628/171). Looks pretty frightening. Turns o… https://t.co/7FWlNxLTtQ May 29th 2019, 7:05pm |
 |
@FeelTrade $ACAD Spet 25/20 Putspread (10K) trading this afternoon. May 29th 2019, 3:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.